Zhu LL - Search Results

1

Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis.

Zhao XK, Yu L, Cheng ML, Che P, Lu YY, Zhang Q, Mu M, Li H, Zhu LL, Zhu JJ, Hu M, Li P, Liang YD, Luo XH, Cheng YJ, Xu ZX, Ding Q. Zhao XK, et al. Among authors: zhu ll, zhu jj. Sci Rep. 2017 Jun 22;7(1):4032. doi: 10.1038/s41598-017-04317-0. Sci Rep. 2017. PMID: 28642549 Free PMC article.

2

Quantitative assessment of common genetic variations in HLA-DP with hepatitis B virus infection, clearance and hepatocellular carcinoma development.

Yu L, Cheng YJ, Cheng ML, Yao YM, Zhang Q, Zhao XK, Liu HJ, Hu YX, Mu M, Wang B, Yang GZ, Zhu LL, Zhang S. Yu L, et al. Among authors: zhu ll. Sci Rep. 2015 Oct 14;5:14933. doi: 10.1038/srep14933. Sci Rep. 2015. PMID: 26462556 Free PMC article.

3

Carboplatin-induced hematotoxicity among patients with non-small cell lung cancer: Analysis on clinical adverse events and drug-gene interactions.

Cheng YJ, Wu R, Cheng ML, Du J, Hu XW, Yu L, Zhao XK, Yao YM, Long QZ, Zhu LL, Zhu JJ, Huang NW, Liu HJ, Hu YX, Wan F. Cheng YJ, et al. Among authors: zhu ll, zhu jj. Oncotarget. 2017 May 9;8(19):32228-32236. doi: 10.18632/oncotarget.12951. Oncotarget. 2017. PMID: 27802181 Free PMC article.

4

Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies.

Wu R, Cheng YJ, Zhu LL, Yu L, Zhao XK, Jia M, Wen CH, Long XZ, Tang T, He AJ, Zeng YY, Ma ZF, Zheng Z, Ni MZ, Cai GJ. Wu R, et al. Among authors: zhu ll. Oncotarget. 2016 Dec 6;7(49):81870-81879. doi: 10.18632/oncotarget.13250. Oncotarget. 2016. PMID: 27835909 Free PMC article. Review.

5

The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.

Ren T, Zhu J, Zhu L, Cheng M. Ren T, et al. Nutrients. 2017 Feb 27;9(3):198. doi: 10.3390/nu9030198. Nutrients. 2017. PMID: 28264426 Free PMC article.

6

Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury.

Yu L, Zhao XK, Cheng ML, Yang GZ, Wang B, Liu HJ, Hu YX, Zhu LL, Zhang S, Xiao ZW, Liu YM, Zhang BF, Mu M. Yu L, et al. Among authors: zhu ll. Sci Rep. 2017 May 2;7(1):1359. doi: 10.1038/s41598-017-01271-9. Sci Rep. 2017. PMID: 28465509 Free PMC article.

7

CXCL10 accelerates EMT and metastasis by MMP-2 in hepatocellular carcinoma.

Ren T, Zhu L, Cheng M. Ren T, et al. Am J Transl Res. 2017 Jun 15;9(6):2824-2837. eCollection 2017. Am J Transl Res. 2017. PMID: 28670372 Free PMC article.

8

Thymosin-β4 inhibits proliferation and induces apoptosis of hepatic stellate cells through PI3K/AKT pathway.

Zhu L, Cheng M, Liu Y, Yao Y, Zhu Z, Zhang B, Mou Q, Cheng Y. Zhu L, et al. Oncotarget. 2017 Jun 28;8(40):68847-68853. doi: 10.18632/oncotarget.18748. eCollection 2017 Sep 15. Oncotarget. 2017. PMID: 28978161 Free PMC article.

9

Thymosin-β4 Mediates Hepatic Stellate Cell Activation by Interfering with CircRNA-0067835/miR-155/FoxO3 Signaling Pathway.

Zhu L, Ren T, Zhu Z, Cheng M, Mou Q, Mu M, Liu Y, Yao Y, Cheng Y, Zhang B, Cheng Z. Zhu L, et al. Cell Physiol Biochem. 2018;51(3):1389-1398. doi: 10.1159/000495556. Epub 2018 Nov 27. Cell Physiol Biochem. 2018. PMID: 30481761 Free article.

10

Platycodin D alleviates liver fibrosis and activation of hepatic stellate cells by regulating JNK/c-JUN signal pathway.

Liu YM, Cong S, Cheng Z, Hu YX, Lei Y, Zhu LL, Zhao XK, Mu M, Zhang BF, Fan LD, Yu L, Cheng ML. Liu YM, et al. Among authors: zhu ll. Eur J Pharmacol. 2020 Jun 5;876:172946. doi: 10.1016/j.ejphar.2020.172946. Epub 2020 Jan 26. Eur J Pharmacol. 2020. PMID: 31996320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

520 results

Search Page

Filters